BBP — Virtus Biotech ETF
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
Company profile
- Sector: Financial Services
- Industry: Asset Management
- Country: US
- Exchange: AMEX
- Website: https://www.virtus.com/products/virtus-biotech-etf#shareclass./period.quarterly
Latest BBP news
- — BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels (globenewswire.com)
Educational tool only — not investment advice.